Newsbenzinga
Doximity's AI Expansion Raises Execution Risks: Analyst
· Published
Article summary
BofA downgrades Doximity (DOCS) to Underperform, slashing the price target to $20 amid soft pharma ad demand and AI execution risks.
An excerpt from the original article.
Comments —
Loading comments…